◀ Back to IRF6

IRF6 — VIPR1

Text-mined interactions from Literome

Yu et al., Peptides 2009 (Inflammation) : It was also found that, in ordinary condition, treatment with PAC1 agonist maxadilan induced marked increase in serum leptin, leptin : SLR ratios and resistin levels ; while in LPS induced inflammation, VPAC1 mediated much more anti-inflammatory and reversing-LPS effects of PACAP on leptin and resistin than PAC1 and VPAC2
Cocco et al., PloS one 2010 : In particular, the bacterial liposaccharide (LPS) , a strong activator of the innate immune system, induces a rapid decrease of VPAC1 expression in monocytes and this event correlates with polymorphisms in the 3'-UTR of the gene
Storka et al., Journal of translational medicine 2013 : In these cells, LPS up-regulated VPAC1 at 6 h ( 13.2?±?4.9 %, p? < ?0.001 ) and 24 h ( 31.6?±?20.5 %, p?=?0.001 ), respectively